These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16168669)

  • 1. Solubility-enhancing proteins MBP and NusA play a passive role in the folding of their fusion partners.
    Nallamsetty S; Waugh DS
    Protein Expr Purif; 2006 Jan; 45(1):175-82. PubMed ID: 16168669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A favorable solubility partner for the recombinant expression of streptavidin.
    Sørensen HP; Sperling-Petersen HU; Mortensen KK
    Protein Expr Purif; 2003 Dec; 32(2):252-9. PubMed ID: 14965771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unrelated solubility-enhancing fusion partners MBP and NusA utilize a similar mode of action.
    Raran-Kurussi S; Waugh DS
    Biotechnol Bioeng; 2014 Dec; 111(12):2407-11. PubMed ID: 24942647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The solubility and stability of recombinant proteins are increased by their fusion to NusA.
    De Marco V; Stier G; Blandin S; de Marco A
    Biochem Biophys Res Commun; 2004 Sep; 322(3):766-71. PubMed ID: 15336530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving solubility of Shewanella oneidensis MR-1 and Clostridium thermocellum JW-20 proteins expressed into Esherichia coli.
    Kataeva I; Chang J; Xu H; Luan CH; Zhou J; Uversky VN; Lin D; Horanyi P; Liu ZJ; Ljungdahl LG; Rose J; Luo M; Wang BC
    J Proteome Res; 2005; 4(6):1942-51. PubMed ID: 16335938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of fusion partners for high yield expression and purification of bioactive viscotoxins.
    Bogomolovas J; Simon B; Sattler M; Stier G
    Protein Expr Purif; 2009 Mar; 64(1):16-23. PubMed ID: 18983922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New fusion protein systems designed to give soluble expression in Escherichia coli.
    Davis GD; Elisee C; Newham DM; Harrison RG
    Biotechnol Bioeng; 1999 Nov; 65(4):382-8. PubMed ID: 10506413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overproduction of a C5a receptor antagonist (C5aRA) in Escherichia coli.
    Jang SH; Jeong KJ
    Protein Expr Purif; 2013 Jun; 89(2):169-74. PubMed ID: 23537791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ability to enhance the solubility of its fusion partners is an intrinsic property of maltose-binding protein but their folding is either spontaneous or chaperone-mediated.
    Raran-Kurussi S; Waugh DS
    PLoS One; 2012; 7(11):e49589. PubMed ID: 23166722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyper-acidic protein fusion partners improve solubility and assist correct folding of recombinant proteins expressed in Escherichia coli.
    Zou Z; Cao L; Zhou P; Su Y; Sun Y; Li W
    J Biotechnol; 2008 Jul; 135(4):333-9. PubMed ID: 18599143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single amino acid substitutions on the surface of Escherichia coli maltose-binding protein can have a profound impact on the solubility of fusion proteins.
    Fox JD; Kapust RB; Waugh DS
    Protein Sci; 2001 Mar; 10(3):622-30. PubMed ID: 11344330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High level soluble production of functional ribonuclease inhibitor in Escherichia coli by fusing it to soluble partners.
    Guo W; Cao L; Jia Z; Wu G; Li T; Lu F; Lu Z
    Protein Expr Purif; 2011 Jun; 77(2):185-92. PubMed ID: 21292012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble expression of archaeal proteins in Escherichia coli by using fusion-partners.
    Kim S; Lee SB
    Protein Expr Purif; 2008 Nov; 62(1):116-9. PubMed ID: 18657619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced fit of passenger proteins fused to Archaea maltose binding proteins.
    Huang H; Liu J; de Marco A
    Biochem Biophys Res Commun; 2006 May; 344(1):25-9. PubMed ID: 16615999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assistance of maltose binding protein to the in vivo folding of the disulfide-rich C-terminal fragment from Plasmodium falciparum merozoite surface protein 1 expressed in Escherichia coli.
    Planson AG; Guijarro JI; Goldberg ME; Chaffotte AF
    Biochemistry; 2003 Nov; 42(45):13202-11. PubMed ID: 14609331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing the solubility of recombinant proteins in Escherichia coli by using hexahistidine-tagged maltose-binding protein as a fusion partner.
    Sun P; Tropea JE; Waugh DS
    Methods Mol Biol; 2011; 705():259-74. PubMed ID: 21125392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled intracellular processing of fusion proteins by TEV protease.
    Kapust RB; Waugh DS
    Protein Expr Purif; 2000 Jul; 19(2):312-8. PubMed ID: 10873547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cu/Zn incorporation during purification of soluble human EC-SOD from E. coli stabilizes proper disulfide bond formation.
    Bae JY; Koo BK; Ryu HB; Song JA; Nguyen MT; Vu TT; Son YJ; Lee HK; Choe H
    Appl Biochem Biotechnol; 2013 Mar; 169(5):1633-47. PubMed ID: 23329142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced solubility of heterologous proteins by fusion expression using stress-induced Escherichia coli protein, Tsf.
    Han KY; Song JA; Ahn KY; Park JS; Seo HS; Lee J
    FEMS Microbiol Lett; 2007 Sep; 274(1):132-8. PubMed ID: 17608803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble expression of a functionally active Plasmodium falciparum falcipain-2 fused to maltose-binding protein in Escherichia coli.
    Goh LL; Loke P; Singh M; Sim TS
    Protein Expr Purif; 2003 Dec; 32(2):194-201. PubMed ID: 14965764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.